Galenica Acquires Aspreva for US$915 M
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 89 (Table of Contents)
Published: 7 Nov-2007
DOI: 10.3833/pdr.v2007.i89.270 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Aspreva Pharmaceuticals has entered into a combination agreement with Galenica through which a Canadian subsidiary will acquire all the Aspreva’s outstanding shares at a transaction value of about US$915 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS